Interstitial Lung Disease Flashcards
Definition of idiopathic interstitial pneumonia
Spectrum of pulmonary disorders with characteristic alveolitic change secondary to infilration of immune cells into pulmonary interstitium
Alveolitic pattern of interstitial lung disease characterized by activated macrophages, T-cells, and inflammatory cytokines that activate B-cells to secrete antibodies
Idiopathic interstitial pneumonia
MOA of idiopatich interstitial pneumonia
antibody/antigen complex deposition in lung parenchyma > activation of complement system > inflammatory reaction with parenchymal tissue injury
further destruction by neutrophils, macrophages (TNF, IL-1), prostaglandins, and cytokines
ultimatley, inflammation and injury may result in irreversible fibrosis
Sx of idiopathic interstitial pneumonia
progressive dyspnea and non-productive cough (over months - years)
Diagnostic w/u for idiopathic interstitial pneumonia
H&P
ABG
PFTs
Labs
Bronchoscopy
High-resolution CT
Biopsy (usually surgical, occasional transbronchial)
Success of transbronchial biopsy for diagnosis in idiopathic interstitial pneumonia
25%
Treatment plan for idiopathic interstitial pneumonia
- Oxygen supplementation
- Removal of causitive agents
- Early intervention to prevent progression of fibrosis
Cornerstone of therapy for interstitial lung disease
Steroids
- 20% of IPF patients will respond to steroids
- Alternative therapies include:
- cyclophosphamide
- azathioprine
- methotrexate
- penicillamine
- cochicine
- cyclosporine
- INF-gamma
Treatment of interstitial lung disease after failure of medical managment
Lung transplantation
SOC for intersitial lung disease (IPF)
Single lung transplant
Criteria for transplant
- Progressive dyspnea/hypoxia despite maximal medical therapy
- VC <= 60 - 70% predicted
- DLCO <= 50 - 60% predicted
- Age < 60 yrs (double lung transplant) or <65 yrs (single lung transplant)
5- year survival after transplant for IPF
]50-60%
(28-month median survival for IPF with medical treatment alone)
Defined by thickened, fibrotic alveolar interstitium with lymphocytic and plasmacytic infiltration
Usual interstial pneumonia (UIP) / Idiopathic pulmonary fibrosis (IPF)
UIP / IPF demographics
males
age > 50
Etiologies of UIP / IPF
Etiology largely unknown
- Infectious
- hepatitis C
- EBV
- Environmental
- heavy metal dusts
- solvents
- cigarette smoking
- Genetic
- HLA-B15, B8, B12
- Immunologic
- Rheumatoid arthritis
- SLE
- Systemic sclerosis
Most common CT findings with UIP / IPF
- Mediastinal lymphadenopathy
- Lower lobe/subpleural predominance
- Reticurlar or reticulnodular pattern
- Honeycombing cysts
- Ground glass opacities
Diagnosis and Treatmetn of UIP/IPF
- Diagnosis:
- surgical biopsy
- Treatment:
- High dose steroids
- Transplant
Favorable prognostic factors for UIP / IPF
- young age
- disease < 1 year
- active inflammation
- lymphocytosis on BAL
- presence of immune complexes
5 - year survival for UIP / IPF
- Responders (43%)
- Non-responders (20%)
ILD subtype characterized by mildly thickened intersitium, spare infiltration of inlfammatory cells, mild fibrosis and filling of alveoli with macrophages
Desquamative interstitial pneumonia (DIP)
MC affected patient population with DIP
Smokers aged 40-50 years old
ILD subtype characterized by mildly thickened interstitium, infiltration of inflammatory cells, and mild fibrosis in patchy distribution with uniform histology
Nonspecific interstitial pneumonia (NIP)